2000 Cannabis Data Treatment 
The Cannigma
JUNE 13, 2021
Women who regularly use cannabis are more likely to suffer from sleep issues than male cannabis users, a new study has found. The difference, the researchers postulated, could be because women are more sensitive to the effects of cannabis. There are several ways in which cannabis affects biological males and females differently.
Veriheal
OCTOBER 29, 2020
A cannabis database has shown that the American funding which is allocated to cannabis is focused on identifying the negative impacts and adverse effects associated with the plant. The cannabis research database displayed that $1.56 billion was funded into cannabis research between 2000 and 2018. Canada, and the U.K)
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 28, 2021
Dr. Greenshaw is a Fellow of the Royal Society of Arts; a Fellow of the Canadian College of Neuropsychopharmacology (CCNP), for which he served as President from 2000-2002; and a fellow of the Collegium Internationale Neuropsychopharmacologicum (CINP). “We would like to extend a warm welcome to Andy as he joins the team at Entheon.
The Cannigma
AUGUST 5, 2022
Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment? Ketamine treatment for depression may be one of the biggest leaps forward in mental healthcare in decades.
Veriheal
JANUARY 26, 2022
Black Americans are being arrested for cannabis possession laws at a rate of nearly four times that of white Americans despite the fact that the groups consume cannabis at similar rates. Racial Disparity in Cannabis Arrests. Additionally, Black Wisconsinites were 4.2 He states, “U.S He states, “U.S
The Blunt Truth
AUGUST 13, 2019
The public hearing attracted over 100 speakers and 2000 participants. To understand the breadth of issues and gather data on safety we have conducted a public hearing, reviewed the medical literature, and have an open public docket.”. The FDA is collecting data to fill these gaps.
Cannabis Law Report
JULY 2, 2021
Novel therapies and psychedelic treatments are rapidly gaining popularity across large swathes of North America as the awareness of mental health disorders and the revolutionary effects of psychedelics in their treatment become more mainstream. Change is always hard, and the finance world is witness to this. Atai Life Sciences N.V.
Expert insights. Personalized for you.
137 
Let's personalize your content